Fulgent Genetics, Inc.
FLGT
$20.31
-$0.21-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.78M | -42.71M | -164.97M | -163.43M | -165.95M |
| Total Depreciation and Amortization | 24.18M | 24.93M | 25.27M | 25.77M | 25.93M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.89M | 46.08M | 163.87M | 173.00M | 169.65M |
| Change in Net Operating Assets | -21.94M | -7.24M | -13.20M | 1.38M | 12.54M |
| Cash from Operations | 9.36M | 21.06M | 10.98M | 36.72M | 42.18M |
| Capital Expenditure | -40.98M | -40.32M | -39.64M | -25.03M | -24.23M |
| Sale of Property, Plant, and Equipment | 57.00K | 313.00K | 648.00K | 632.00K | 835.00K |
| Cash Acquisitions | -- | -- | -399.00K | -399.00K | -399.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.48M | -18.35M | 32.77M | 29.26M | 19.86M |
| Cash from Investing | 16.56M | -58.35M | -6.63M | 4.47M | -3.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.48M | -1.77M | -3.61M | -5.24M | -20.66M |
| Issuance of Common Stock | 51.00K | 51.00K | 0.00 | 0.00 | 3.00K |
| Repurchase of Common Stock | -11.78M | -3.12M | -26.86M | -29.14M | -28.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.21M | -4.85M | -30.47M | -34.38M | -49.49M |
| Foreign Exchange rate Adjustments | 25.00K | -55.00K | 224.00K | -49.00K | -246.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.74M | -42.19M | -25.90M | 6.76M | -11.50M |